As a first step to framework modernization, the Patented Medicines Prices Review Board (PMPRB) is undertaking major consultations regarding possible reform of its Compendium of Policies, Guidelines and Procedures, commonly referred to as “the Guidelines.” During Phase 1 of this consultation initiative, the PMPRB asked for input on how to rethink ... Read More

The Patented Medicine Prices Review Board (PMPRB) announced the reappointment of Dr. Mitchell Levine of Hamilton, Ontario as Vice-chairperson of the Board for a second five-year term. Dr. Levine is a Professor in the departments of Medicine and Clinical Epidemiology and Biostatistics in the Faculty of Health Sciences at McMaster ... Read More

Information Session on the PMPRB Guidelines Modernization Discussion Paper On August 23rd, 2016, PDCI Market Access Inc., Canada’s leading pricing and reimbursement consultancy, held a free “Information Session on the PMPRB Guidelines Modernization Discussion Paper”. This came shortly after the PMPRB recently releasing its long awaited consultation paper “PMPRB ... Read More

2015 Annual Report Released  Earlier today, the Patented Medicine Prices Review Board (PMPRB), in accordance with sections 89 and 100 of the Patent Act, released its Annual Report for the year ended December 31, 2015. The Annual Report is an extensive document that reviews all of the PMPRB’s major activities, analyses of ... Read More

Results of the Notice and Comment Period on Incremental Reforms to the Compendium of Policies, Guidelines and Procedures On December 4, 2015, the PMPRB announced the start of a Notice and Comment initiative to seek stakeholder feedback on two proposed amendments to the Compendium of Policies, Guidelines and Procedures: the “Reasonable ... Read More

PDCI’s PMPRB Guidelines Modernization Webinar Session On June 24, the PMPRB released its long awaited consultation paper “PMPRB Guidelines Modernization – Discussion Paper, June 2016”.  The paper, the initial phase of a three-part Guideline modernization process, asserts that PMPRB’s current framework is outdated and seeks feedback on a wide range ... Read More

Correction to the below TargetPharma (“PMPRB 2015 Annual Report”) sent out on July 21, 2016. The PMPRB report tabled in Parliament was their report with respect to the Access to Information Act and to the Privacy Act and not the anticipated “2015 PMPRB Annual Report” which was not tabled and now ... Read More